Position in GRFS
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$26,386,513
-$5,588,392 QoQ
Shares Held
3,290,089
-3.8% QoQ
Ownership
0.483%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 95%
None 5%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026JANUS HENDERSON GROUP PLC holds $11,353,030,401 across 14 Drug Manufacturers - General names. GRFS ranks #12 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,347,394 | $3,998,602,577 | |
| 2 | AZN |
Astrazeneca PLC
|
11,949,424 | $2,356,665,399 | |
| 3 | JNJ |
Johnson & Johnson
|
7,872,478 | $1,924,348,519 | |
| 4 | ABBV |
AbbVie Inc.
|
6,931,036 | $1,507,431,018 | |
| 5 | AMGN |
Amgen Inc
|
1,107,159 | $389,553,892 | |
| 6 | NVS |
Novartis AG
|
2,275,938 | $347,649,529 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,880,199 | $346,459,135 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,972,639 | $274,926,696 |
All Filings in GRFS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,386,513 | 3,290,089 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $31,974,905 | 3,419,776 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $34,362,069 | 3,450,007 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $28,926,490 | 3,199,833 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $21,651,798 | 3,045,260 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $22,656,734 | 3,045,260 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $24,157,072 | 2,720,391 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $20,581,724 | 3,261,763 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $9,955,698 | 1,490,374 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $21,009,999 | 1,817,474 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $20,545,147 | 2,247,828 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $20,564,529 | 2,245,036 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $17,052,448 | 2,313,765 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $20,797,120 | 2,446,720 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $13,963,685 | 2,266,832 | Shares | Defined | 2023-01-13 | |
| 2022-06-30 | $48,888,552 | 4,115,198 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $45,795,387 | 3,920,838 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $60,760,487 | 5,410,551 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $69,465,904 | 4,754,682 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $77,020,848 | 4,439,242 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $64,071,310 | 3,705,686 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $62,678,131 | 3,399,031 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $59,464,852 | 3,427,369 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $62,927,379 | 3,449,966 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $81,027,731 | 4,023,224 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||